Ep-Cam Case Study

197 Words1 Page

Ep-CAM was selected as target antigen for several immunotherapeutic approaches due to its frequent and high-level expression on carcinomas (Balzar et al., 1999).The first monoclonal antibody applied for human cancer therapy of gastrointestinal tumors was the EpCAM-directed monoclonal antibody 17-1A (Sears et al., 1984). In patients with metastatic breast cancer, the human anti-EpCAM antibody adecatumumab was used in treatment (Schmidt et al., 2010). It is important to determine human cancers that are eligible for EpCAM-specific immunotherapy based on EpCAM expression according to intensity, frequency and disease stage (Went et al., 2006).
Its high-level, frequent and homogenous expression on human adenocarcinoma make Ep-CAM an ideal target

More about Ep-Cam Case Study

Open Document